Free Trial

BKV (NYSE:BKV) Coverage Initiated by Analysts at Citigroup

BKV Corporation logo

Citigroup assumed coverage on shares of BKV (NYSE:BKV - Free Report) in a report published on Monday, Marketbeat Ratings reports. The firm issued a buy rating and a $29.00 price objective on the stock.

Other equities research analysts have also issued reports about the company. KeyCorp initiated coverage on BKV in a research report on Monday. They set an "overweight" rating and a $23.00 price target on the stock. Barclays started coverage on BKV in a research report on Monday. They issued an "overweight" rating and a $24.00 price objective on the stock. Mizuho started coverage on BKV in a research report on Monday. They issued an "outperform" rating and a $29.00 price objective on the stock. Jefferies Financial Group started coverage on BKV in a research report on Monday. They issued a "buy" rating and a $28.00 price objective on the stock. Finally, Evercore ISI started coverage on BKV in a research report on Monday. They issued an "outperform" rating and a $24.00 price objective on the stock. Six investment analysts have rated the stock with a buy rating, Based on data from MarketBeat, the company currently has an average rating of "Buy" and an average target price of $26.17.

Get Our Latest Research Report on BKV

BKV Stock Performance

NYSE BKV traded up $0.02 during trading hours on Monday, reaching $18.47. 287,712 shares of the company's stock were exchanged, compared to its average volume of 484,442. BKV has a one year low of $17.90 and a one year high of $18.88.

Insider Transactions at BKV

In related news, CFO John T. Jimenez purchased 16,500 shares of BKV stock in a transaction dated Friday, September 27th. The shares were acquired at an average cost of $18.00 per share, for a total transaction of $297,000.00. Following the transaction, the chief financial officer now directly owns 273,274 shares of the company's stock, valued at approximately $4,918,932. This trade represents a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. In related news, CFO John T. Jimenez purchased 16,500 shares of BKV stock in a transaction dated Friday, September 27th. The shares were acquired at an average cost of $18.00 per share, for a total transaction of $297,000.00. Following the transaction, the chief financial officer now directly owns 273,274 shares of the company's stock, valued at approximately $4,918,932. This trade represents a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, CEO Christopher P. Kalnin purchased 2,500 shares of BKV stock in a transaction dated Friday, September 27th. The stock was bought at an average price of $18.00 per share, for a total transaction of $45,000.00. Following the completion of the transaction, the chief executive officer now directly owns 1,483,054 shares in the company, valued at $26,694,972. The trade was a 0.00 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have purchased 21,850 shares of company stock worth $393,300 in the last three months.

About BKV

(Get Free Report)

BKV Corporation engages in the acquisition, operation, and development of natural gas and NGL properties. It is also involved in the gathering, processing, and transportation of natural gas. The company was founded in 2015 and is based in Denver, Colorado with additional offices in Tunkhannock, Pennsylvania and Fort Worth, Texas.

Featured Stories

Analyst Recommendations for BKV (NYSE:BKV)

→ Next opportunity for crypto millions (From Crypto 101 Media) (Ad)

Should you invest $1,000 in BKV right now?

Before you consider BKV, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BKV wasn't on the list.

While BKV currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Alphabet Gaining Momentum: Can It Reach $200 by December?

Alphabet Gaining Momentum: Can It Reach $200 by December?

Alphabet (GOOGL) is in the midst of a year-end rally, climbing 10% since September, and some analysts predict it could gain another 30% by Christmas!

Recent Videos

Meta Platforms Tops Most Upgraded Stocks List—Here’s What to Expect
Alphabet Gaining Momentum: Can It Reach $200 by December?
Build-to-Order: The Strategy Fueling Toll Brothers’ Growth

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines